Top Pharmaceuticals stocks in Europe
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
NOVO BNovo Nordisk A/S | DKK3.92tn | 46.33 | 1.07% |
AZNAstraZeneca | £171.52bn | 40.41 | 2.11% |
ROGRoche Holding AG | CH₣179.38bn | 12.5 | 4.27% |
RORoche Holding AG | CH₣179.38bn | 13.44 | 3.97% |
NOVNNovartis AG | CH₣175.99bn | 17.28 | 4.16% |
SANSanofi SA | €108.20bn | 16.37 | 4.35% |
GSKGSK | £68.12bn | 11.71 | 3.53% |
MRKMerck KGaA | €66.78bn | 20.03 | 1.43% |
HLNHALEON | £29.49bn | 22.52 | 1.86% |
BAYNBayer AG | €26.49bn | 4.21 | 0.41% |
UCBUCB SA | €22.89bn | 86.26 | 0.79% |
SDZSandoz AG | CH₣11.57bn | 10.44 | 1.82% |
RECRecordati Industria Chimica E Farmaceutica SpA | €10.18bn | 28.72 | 2.43% |
IPNIpsen SA | €9.04bn | 21.12 | 1.1% |
SOBISwedish Orphan Biovitrum AB (publ) | SEK85.89bn | 29.29 | n/a |
GRFGrifols SA | €5.82bn | 16.66 | n/a |
DPHDechra Pharmaceuticals | £4.40bn | 67.15 | n/a |
CLS1McKesson Europe AG | €4.96bn | n/a | n/a |
HIKHikma Pharmaceuticals | £4.00bn | 10.15 | 2.09% |
ORNBVOrion Oyj | €4.63bn | 24.79 | 4.91% |